Cargando…
Is acriflavine an efficient co-drug in chemotherapy?
Cancer is a global health problem being the second worldwide cause of deaths right after cardiovascular diseases. The main methods of cancer treatment involve surgery, radiation and chemotherapy with an emphasis on the latter. Thus development of nanochemistry and nanomedicine in a search for more e...
Autores principales: | Piorecka, Kinga, Kurjata, Jan, Gostynski, Bartłomiej, Kazmierski, Slawomir, Stanczyk, Wlodzimierz A., Marcinkowska, Monika, Janaszewska, Anna, Klajnert-Maculewicz, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350790/ https://www.ncbi.nlm.nih.gov/pubmed/37465576 http://dx.doi.org/10.1039/d3ra02608f |
Ejemplares similares
-
Hydrophilic Polyhedral Oligomeric Silsesquioxane, POSS(OH)(32), as a Complexing Nanocarrier for Doxorubicin and Daunorubicin
por: Piorecka, Kinga, et al.
Publicado: (2020) -
Acriflavine,
an Acridine Derivative for Biomedical
Application: Current State of the Art
por: Piorecka, Kinga, et al.
Publicado: (2022) -
In Vitro Studies of Polyhedral Oligo Silsesquioxanes: Evidence for Their Low Cytotoxicity
por: Janaszewska, Anna, et al.
Publicado: (2015) -
Unusual Enhancement of Doxorubicin Activity on Co-Delivery with Polyhedral Oligomeric Silsesquioxane (POSS)
por: Sobierajska, Ewelina, et al.
Publicado: (2017) -
Multicomponent Conjugates of Anticancer Drugs and Monoclonal Antibody with PAMAM Dendrimers to Increase Efficacy of HER-2 Positive Breast Cancer Therapy
por: Marcinkowska, Monika, et al.
Publicado: (2019)